Primary Chemotherapy in Breast Cancer: The Beginning of the End or the End of the Beginning for the Surgical Oncologist?

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2003 Aug 23

PMID 12932299

Citations 4

Authors

Steven D Heys

Shailesh Chaturvedi

Affiliations

Soon will be listed here.

Citing Articles

Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy.

Sekine C, Uchiyama N, Watase C, Murata T, Shiino S, Jimbo K Mol Clin Oncol. 2022; 16(2):50.

PMID: 35070299 PMC: 8764658. DOI: 10.3892/mco.2021.2483.

P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy-a Prospective Clinical Study from a Developing Country.

Mehrotra M, Anand A, Singh K, Kumar S, Husain N, Sonkar A Indian J Surg Oncol. 2018; 9(4):524-529.

PMID: 30538383 PMC: 6265170. DOI: 10.1007/s13193-018-0797-8.

FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.

Sheikhbahaei S, Trahan T, Xiao J, Taghipour M, Mena E, Connolly R Oncologist. 2016; 21(8):931-9.

PMID: 27401897 PMC: 4978549. DOI: 10.1634/theoncologist.2015-0353.

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.

Chintamani , Singh J, Mittal M, Saxena S, Bansal A, Bhatia A World J Surg Oncol. 2005; 3:61.

PMID: 16164742 PMC: 1224882. DOI: 10.1186/1477-7819-3-61.

References

Napolitano U, Imperato F, Mossa B, Framarino M, Marziani R, Marzetti L . The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaecol Oncol. 2003; 24(1):51-9. View

Swain S, Sorace R, Bagley C, Danforth Jr D, Bader J, Wesley M . Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 1987; 47(14):3889-94. View

De Lena M, ZUCALI R, Viganotti G, Valagussa P, Bonadonna G . Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol. 1978; 1(1):53-9. DOI: 10.1007/BF00253147. View

DeLaney T, Spiro I, Suit H, Gebhardt M, Hornicek F, Mankin H . Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003; 56(4):1117-27. DOI: 10.1016/s0360-3016(03)00186-x. View

HAAGENSEN C, STOUT A . Carcinoma of the Breast. II-Criteria of Operability. Ann Surg. 1943; 118(6):1032-51. PMC: 1617775. DOI: 10.1097/00000658-194312000-00010. View

Smith I, Jones A, OBrien M, McKinna J, Sacks N, Baum M . Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer. 1993; 29A(12):1796-9. DOI: 10.1016/0959-8049(93)90133-z. View

Smith I, Heys S, Hutcheon A, Miller I, Payne S, Gilbert F . Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 2002; 20(6):1456-66. DOI: 10.1200/JCO.2002.20.6.1456. View

Urschel J, Vasan H . A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003; 185(6):538-43. DOI: 10.1016/s0002-9610(03)00066-7. View

Menges M, Schmidt C, Lindemann W, Ridwelski K, Pueschel W, Jungling B . Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate. J Cancer Res Clin Oncol. 2003; 129(7):423-9. DOI: 10.1007/s00432-003-0467-1. View

10.

Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher E . Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998; 16(8):2672-85. DOI: 10.1200/JCO.1998.16.8.2672. View

11.

Amat S, Bougnoux P, Penault-Llorca F, Fetissof F, Cure H, Kwiatkowski F . Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer. 2003; 88(9):1339-45. PMC: 2741049. DOI: 10.1038/sj.bjc.6600916. View

12.

Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B . Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2002; (30):96-102. DOI: 10.1093/oxfordjournals.jncimonographs.a003469. View

13.

McIntosh S, Ogston K, Payne S, Miller I, Sarkar T, Hutcheon A . Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg. 2003; 185(6):525-31. DOI: 10.1016/s0002-9610(03)00078-3. View

14.

Mazzeo F, Berliere M, Kerger J, Squifflet J, Duck L, DHondt V . Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol. 2003; 90(1):163-9. DOI: 10.1016/s0090-8258(03)00249-x. View

15.

Simmonds P, Mead G, Lee A, Theaker J, Dewbury K, Smart C . Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?. Cancer. 1995; 75(4):1018-24. DOI: 10.1002/1097-0142(19950215)75:4<1018::aid-cncr2820750418>3.0.co;2-y. View

16.

Bonadonna G, Valagussa P . Primary chemotherapy in operable breast cancer. Semin Oncol. 1996; 23(4):464-74. View

17.

SHELDON P, Fowler J . The effect of irradiating a transplanted murine lymphosarcoma on the subsequent development of metastases. Br J Cancer. 1973; 28(6):508-14. PMC: 2008934. DOI: 10.1038/bjc.1973.180. View

18.

Halsted W . I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg. 1907; 46(1):1-19. PMC: 1414357. DOI: 10.1097/00000658-190707000-00001. View

19.

. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998; 352(9132):930-42. View

20.

Fisher B, Gunduz N, Saffer E . Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 1983; 43(4):1488-92. View